Stock vs Stock Comparison

Alkermes plc vs Abbott Laboratories

ALKS wins the Tale of the Tape 6–2.

ALKS
ABT$86.99

🏆 Tale of the Tape

62
ALKSABT
16.4%Profitability (Net Margin)14.7%
20.8xValuation (P/E)24.0x
12.3%Efficiency (ROIC)10.1%
5/9Health (Piotroski F)5/9
5.7Safety (Altman Z)4.9
-5.3%Growth (Rev YoY)5.7%
Risk (Sharpe 1Y)-1.05
0.37xBalance Sheet (D/E)0.64x
10.53%FCF Yield4.21%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Fundamentals

MetricALKSABT
Market Cap$5.0B$149.1B
P/E Ratio20.8x24.0x
Forward P/E14.9x14.1x
P/B2.70x2.86x
Dividend Yield2.94%
Beta0.490.65

Quantitative Metrics

MetricALKSABT
DCF Fair Value$70.29$57.20
DCF Upside-43.2%
Piotroski F5/95/9
Altman Z5.704.87
Beneish M-3.30-2.53
FCF Yield10.53%4.21%
Net Debt/EBITDA0.1x
ROIC12.3%10.1%
WACC9.4%
ROIC – WACC0.7pp
Gross Margin86.7%56.4%
Net Margin16.4%14.7%
Rev Growth YoY-5.3%5.7%
Sharpe (1Y)-1.05
Max Drawdown 3Y
FCF Payout Ratio56%

ALKS Price

Loading chart...

ABT Price

Loading chart...

ETF Exposure

ALKS found in:

XBI1.54%
SLYG0.73%
VFQY0.52%
SPSM0.36%
VBK0.17%
VTWO0.16%
VHT0.09%
VB0.07%
VXF0.07%
VFVA0.06%
SPTM0.01%

ABT found in:

IHI16.06%
IYH2.88%
XLV2.85%
VHT2.55%
DGRW1.71%
XHE1.36%
NOBL1.34%
SDY0.99%
MGV0.78%
VIG0.71%
VFMV0.69%
SCHV0.68%
VYM0.65%
VTV0.61%
IWD0.58%
QUS0.57%
SPYV0.53%
VONV0.48%
IVV0.37%
SPLG0.37%
ESGV0.36%
ITOT0.33%
SCHX0.33%
SCHB0.30%
VOO0.26%
VONE0.24%
SPY0.24%
URTH0.24%
VTI0.23%
SPTM0.22%
ACWI0.20%
RSP0.17%
VT0.14%
ONEO0.08%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

ALKS vs ABT: Head-to-Head Analysis

Alkermes plc (ALKS) and Abbott Laboratories (ABT) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, ALKS leads 6–2 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, ALKS generates a return on invested capital (ROIC) of 12.3% compared to ABT's 10.1%. This suggests ALKS is more effective at deploying capital to generate shareholder returns.

ALKS appears in 11 ETFs tracked by SecuritiesDB, while ABT appears in 34 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, ALKS or ABT?

Our quantitative analysis compares ALKS and ABT across nine fundamental dimensions. ALKS wins the Tale of the Tape 6–2. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are ALKS and ABT correlated?

Correlation data is not yet available for this pair. Check back after both stocks have sufficient trading history.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.